2nd Quarter - Report

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Firm
Client
Income
—
Expenses
$890,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; artificial intelligence in laboratory services; laboratory coding, pricing, coverage, and payment.

LobbyistCovered position, as disclosed
HOLLY BRUGGEN —
LAURA STEVENS KENT Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood
SUSAN VAN METER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5269 (119th), S. 2761 (119th)

Medicare/Medicaid MMM

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.

LobbyistCovered position, as disclosed
HOLLY BRUGGEN —
LAURA STEVENS KENT Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood
SUSAN VAN METER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5269 (119th), S. 2761 (119th), H.R. 9396 (119th), S. 1816 (119th), H.R. 3514 (119th)

Health Issues HCR

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393).

LobbyistCovered position, as disclosed
HOLLY BRUGGEN —
LAURA STEVENS KENT Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2355 (119th), S. 2761 (119th), H.R. 5582 (119th), H.R. 9393 (119th), H.R. 5269 (119th)

Immigration IMM

H-1Bs for Physicians and Healthcare Workforce Act (H.R. 7961).

LobbyistCovered position, as disclosed
HOLLY BRUGGEN —
LAURA STEVENS KENT Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 7961 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.